QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 11, 2007, 27(28):7459-7468; doi:10.1523/JNEUROSCI.1483-07.2007

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (36) Citing Articles via Google Scholar Google Scholar Articles by Steiner, A. A. Articles by Romanovsky, A. A. Search for Related Content PubMed PubMed Citation Articles by Steiner, A. A. Articles by Romanovsky, A. A.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Nonthermal Activation of Transient Receptor Potential Vanilloid-1 Channels in Abdominal Viscera Tonically Inhibits Autonomic Cold-Defense Effectors

Alexandre A. Steiner,¹ Victoria F. Turek,¹ Maria C. Almeida,¹ Jeffrey J. Burmeister,¹ Daniela L. Oliveira,¹ Jennifer L. Roberts,¹ Anthony W. Bannon,² Mark H. Norman,³ Jean-Claude Louis,² James J. S. Treanor,² Narender R. Gavva,² and Andrej A. Romanovsky¹

¹Systemic Inflammation Laboratory, Trauma Research, St. Joseph's Hospital, Phoenix, Arizona 85013, and Departments of ²Neuroscience and ³Chemistry Research and Discovery, Amgen, Thousand Oaks, California 91320

Correspondence should be addressed to either of the following: Andrej A. Romanovsky, Systemic Inflammation Laboratory, Trauma Research, St. Joseph's Hospital, 350 West Thomas Road, Phoenix, AZ 85013, Email: aromano{at}chw.edu; or Narender R. Gavva, Department of Neuroscience, Amgen, One Amgen Center Drive, Thousand Oaks, CA 91320, Email: ngavva{at}amgen.com

An involvement of the transient receptor potential vanilloid (TRPV) 1 channel in the regulation of body temperature (T_b) has not been established decisively. To provide decisive evidence for such an involvement and determine its mechanisms were the aims of the present study. We synthesized a new TRPV1 antagonist, AMG0347 [(E)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-3-(2-(piperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)acrylamide], and characterized it in vitro. We then found that this drug is the most potent TRPV1 antagonist known to increase T_b of rats and mice and showed (by using knock-out mice) that the entire hyperthermic effect of AMG0347 is TRPV1 dependent. AMG0347-induced hyperthermia was brought about by one or both of the two major autonomic cold-defense effector mechanisms (tail-skin vasoconstriction and/or thermogenesis), but it did not involve warmth-seeking behavior. The magnitude of the hyperthermic response depended on neither T_b nor tail-skin temperature at the time of AMG0347 administration, thus indicating that AMG0347-induced hyperthermia results from blockade of tonic TRPV1 activation by nonthermal factors. AMG0347 was no more effective in causing hyperthermia when administered into the brain (intracerebroventricularly) or spinal cord (intrathecally) than when given systemically (intravenously), which indicates a peripheral site of action. We then established that localized intra-abdominal desensitization of TRPV1 channels with intraperitoneal resiniferatoxin blocks the T_b response to systemic AMG0347; the extent of desensitization was determined by using a comprehensive battery of functional tests. We conclude that tonic activation of TRPV1 channels in the abdominal viscera by yet unidentified nonthermal factors inhibits skin vasoconstriction and thermogenesis, thus having a suppressive effect on T_b.

Key words: TRPV1; channel; chemosensory; afferent; temperature; hyperthermia

---

Received April 2, 2007; revised May 24, 2007; accepted June 4, 2007.

Correspondence should be addressed to either of the following: Andrej A. Romanovsky, Systemic Inflammation Laboratory, Trauma Research, St. Joseph's Hospital, 350 West Thomas Road, Phoenix, AZ 85013, Email: aromano{at}chw.edu; or Narender R. Gavva, Department of Neuroscience, Amgen, One Amgen Center Drive, Thousand Oaks, CA 91320, Email: ngavva{at}amgen.com

This article has been cited by other articles:

				A. M. Patwardhan, P. E. Scotland, A. N. Akopian, and K. M. Hargreaves From the Cover: Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia PNAS, November 3, 2009; 106(44): 18820 - 18824. [Abstract] [Full Text] [PDF]

				S. S. Ayoub, J. C. Hunter, and D. L. Simmons Answering the Burning Question of How Transient Receptor Potential Vanilloid-1 Channel Antagonists Cause Unwanted Hyperthermia Pharmacol. Rev., September 1, 2009; 61(3): 225 - 227. [Abstract] [Full Text] [PDF]

				A. A. Romanovsky, M. C. Almeida, A. Garami, A. A. Steiner, M. H. Norman, S. F. Morrison, K. Nakamura, J. J. Burmeister, and T. B. Nucci The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is Not Pharmacol. Rev., September 1, 2009; 61(3): 228 - 261. [Abstract] [Full Text] [PDF]

				D. Ni and L.-Y. Lee Lack of potentiating effect of increasing temperature on responses to chemical activators in vagal sensory neurons isolated from TRPV1-null mice Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L897 - L904. [Abstract] [Full Text] [PDF]

				T. Katsumata, H. Nakakuki, C. Tokunaga, N. Fujii, M. Egi, T.-H. T. Phan, S. Mummalaneni, J. A. DeSimone, and V. Lyall Effect of Maillard Reacted Peptides on Human Salt Taste and the Amiloride-Insensitive Salt Taste Receptor (TRPV1t) Chem Senses, September 1, 2008; 33(7): 665 - 680. [Abstract] [Full Text] [PDF]

				O. Fajardo, V. Meseguer, C. Belmonte, and F. Viana TRPA1 Channels Mediate Cold Temperature Sensing in Mammalian Vagal Sensory Neurons: Pharmacological and Genetic Evidence J. Neurosci., July 30, 2008; 28(31): 7863 - 7875. [Abstract] [Full Text] [PDF]

				S. G. Lehto, R. Tamir, H. Deng, L. Klionsky, R. Kuang, A. Le, D. Lee, J.-C. Louis, E. Magal, B. H. Manning, et al. Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 218 - 229. [Abstract] [Full Text] [PDF]

				S. F. Morrison, K. Nakamura, and C. J. Madden Central control of thermogenesis in mammals Exp Physiol, July 1, 2008; 93(7): 773 - 797. [Abstract] [Full Text] [PDF]

				Y. Ootsuka, W. W. Blessing, A. A. Steiner, and A. A. Romanovsky Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1294 - R1303. [Abstract] [Full Text] [PDF]

				P. M. Blumberg Lighting a Backfire to Quench the Blaze: A Combined Drug Approach Targeting the Vanilloid Receptor TRPV1 Mol. Interv., December 1, 2007; 7(6): 310 - 312. [Abstract] [Full Text] [PDF]

				N. R. Gavva, A. W. Bannon, D. N. Hovland Jr., S. G. Lehto, L. Klionsky, S. Surapaneni, D. C. Immke, C. Henley, L. Arik, A. Bak, et al. Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 128 - 137. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help